Acorda Therapeutics (ACOR) Q4 2022 Earnings

9MarConfirmed
May 22
Aug 22
Nov 22
Q4 2022
-2.78
-1.66
-0.55
0.57

Details

Expected EPS
N/A
Actual EPS
0.57
Surprise EPS
0.57
Surprise Percent
+∞%

Description

Acorda Therapeutics (ACOR) has reported earnings of 0.57 per share for Q4 2022.

0 Comments

Share your thoughts